Abstract Purpose of Review The association between plasma Trimethylamine N-Oxide
(TMAO), diet and risk for cardiovascular disease (CVD) is still not fully understood. While …

Abstract Circulating trimethylamine N-Oxide (TMAO) levels predict cardiovascular disease
(CVD), possibly by impacting on cholesterol metabolism and oxidative stress. Because …

Background: Elevated plasma concentrations of the gut bacteria choline metabolite
trimethylamine N-oxide (TMAO) are associated with atherosclerosis. However, the …

Background Trimethylamine‐N‐oxide (TMAO), a diet‐derived, gut microbial–host
cometabolite, has been associated with adverse cardiovascular outcomes in patient …

Abstract Purpose of Review Trimethylamine N-oxide (TMAO) is a gut microbiota-dependent
metabolite produced from choline and phosphatidylcholine. Trimethylamine N-oxide was …

Accumulating evidence linking trimethylamine N-oxide (TMAO) to cardiovascular disease
(CVD) risk has prompted interest in developing therapeutic strategies to reduce its …

Circulating trimethylamine N‐oxide (TMAO), a canonical metabolite from gut flora, has been
related to the risk of cardiovascular disorders. However, the association between circulating …

Background Microflora-dependent trimethylamine-N-oxide (TMAO) formation, which results
from intake of choline and L-carnitine-rich food, shows promise as a predictor of …

ABSTRACT Background Trimethylamine N-oxide (TMAO), a diet-derived, gut microbial-host
cometabolite, has been linked to cardiometabolic diseases. However, the relations remain …

Background Previous clinical studies have suggested that trimethylamine-N-oxide (TMAO)
could contribute to the development of atherosclerosis cardiovascular disease. However, the …